Literature DB >> 9218504

CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.

R M Zwacka1, Y Zhang, J Halldorson, H Schlossberg, L Dudus, J F Engelhardt.   

Abstract

The success of orthotopic liver transplantation is dependent on multiple factors including MHC tissue compatibility and ischemic/reperfusion injury. Ischemic/reperfusion (I/R) injury in the liver occurs in a biphasic pattern consisting of both acute phase (oxygen free radical mediated) and subacute phase (neutrophil-mediated) damage. Although numerous studies have given insights into the process of neutrophil recruitment after I/R injury to the liver, the exact mechanism that initiates this subacute response remains undefined. Using a T cell-deficient mouse model, we present data that suggests that T-lymphocytes are key mediators of subacute neutrophil inflammatory responses in the liver after ischemia and reperfusion. To this end, using a partial lobar liver ischemia model, we compared the extent of reperfusion injury between immune competent BALB/c and athymic nu/nu mice. Studies evaluating the extent of liver damage as measured by serum transaminases (GPT) demonstrate similar acute (3-6 h) post-I/R responses in these two mouse models. In contrast, the subacute phase (16-20 h) of liver injury, as measured by both serum GPT levels and percent hepatocellular necrosis, was dramatically reduced in T cell-deficient mice as compared with those with an intact immune system. This reduction in liver injury seen in nu/nu mice was associated with a 10-fold reduction in hepatic neutrophil infiltration. Adoptive transfer of T cell-enriched splenocytes from immune competent mice was capable of reconstituting the neutrophil-mediated subacute inflammatory response within T cell-deficient nu/nu mice. Furthermore, in vivo antibody depletion of CD4(+) T-lymphocytes in immune competent mice resulted in a reduction of subacute phase injury and inflammation as measured by serum GPT levels and neutrophil infiltration. In contrast, depletion of CD8(+) T-lymphocytes had no effect on these indexes of subacute inflammation. Kinetic analysis of T cell infiltration in the livers of BALB/c mice demonstrated a fivefold increase in the number of hepatic CD4(+) T-lymphocytes within the first hour of reperfusion with no significant change in the number of CD8(+) T-lymphocytes. In summary, these results implicate CD4(+) T-lymphocytes as key regulators in initiating I/R-induced inflammatory responses in the liver. Such findings have implications for therapy directed at the early events in this inflammatory cascade that may prove useful in liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218504      PMCID: PMC508190          DOI: 10.1172/JCI119533

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  A new slow delivery type of superoxide dismutase prevents warm ischemia damage in swine orthotopic liver transplantation.

Authors:  H Hasuoka; K Sakagami; K Orita
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia.

Authors:  H Jaeschke; A P Bautista; Z Spolarics; J J Spitzer
Journal:  Free Radic Res Commun       Date:  1991

Review 3.  Reperfusion injury.

Authors:  J T Flaherty; M L Weisfeldt
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

4.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

5.  Hypoxic damage generates reactive oxygen species in isolated perfused rat liver.

Authors:  H Jaeschke; C V Smith; J R Mitchell
Journal:  Biochem Biophys Res Commun       Date:  1988-01-29       Impact factor: 3.575

6.  Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo.

Authors:  H Jaeschke; A Farhood; C W Smith
Journal:  FASEB J       Date:  1990-12       Impact factor: 5.191

7.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

Authors:  P Ghezzi; C A Dinarello; M Bianchi; M E Rosandich; J E Repine; C W White
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

9.  Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver.

Authors:  H Jaeschke; A Farhood; A P Bautista; Z Spolarics; J J Spitzer; C W Smith
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

10.  Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion.

Authors:  A Koo; H Komatsu; G Tao; M Inoue; P H Guth; N Kaplowitz
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

View more
  104 in total

1.  Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.

Authors:  Maria Cecilia S Freitas; Yoichiro Uchida; Danyun Zhao; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

2.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation.

Authors:  Benjamin H Friedman; Joshua H Wolf; Liqing Wang; Mary E Putt; Abraham Shaked; Jason D Christie; Wayne W Hancock; Kim M Olthoff
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

4.  HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.

Authors:  Bibo Ke; Xiu-Da Shen; Haofeng Ji; Naoko Kamo; Feng Gao; Maria Cecilia S Freitas; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

5.  End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.

Authors:  Richard T Robinson; Jing Wang; James G Cripps; Michael W Milks; Kathryn A English; Todd A Pearson; James D Gorham
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.

Authors:  Yuan-Ji Day; Liping Huang; Marcia J McDuffie; Diane L Rosin; Hong Ye; Jiang-Fan Chen; Michael A Schwarzschild; J Stephen Fink; Joel Linden; Mark D Okusa
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 7.  Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

Authors:  Yuan Zhai; Henrik Petrowsky; Johnny C Hong; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

8.  Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury.

Authors:  Takashi Hamada; Seiichiro Tsuchihashi; Armine Avanesyan; Sergio Duarte; Carolina Moore; Ronald W Busuttil; Ana J Coito
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.

Authors:  Maureen Shuh; Humberto Bohorquez; George E Loss; Ari J Cohen
Journal:  Ochsner J       Date:  2013

10.  Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.

Authors:  Rebecca A Sosa; Ali Zarrinpar; Maura Rossetti; Charles R Lassman; Bita V Naini; Nakul Datta; Ping Rao; Nicholas Harre; Ying Zheng; Roberto Spreafico; Alexander Hoffmann; Ronald W Busuttil; David W Gjertson; Yuan Zhai; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.